CRL logo

CRLCharles River Laboratories International Inc.

$187.51
$0.55
(0.29%)
Today
Closed $187.51
$0.00
(0.00%)
After Hours
Updated: 04:58 PM EDT
EarningsAug 5
Mkt Cap$9.03B
Vol493,939.00
News
all
press releases
CRL Crosses Below Key Moving Average Level
In trading on Tuesday, shares of Charles River Laboratories International Inc. (Symbol: CRL) crossed below their 200 day moving average of $176.42, changing hands as low as $172.17 per share. Charles River Laboratories International Inc. shares are currently trading down about...
Nasdaq News: Markets
News Placeholder
More News
News Placeholder
Charles River Laboratories to Present at William Blair and Jefferies Conferences
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the William Blair 46th Annual Growth Stock Conference on Tuesday, June 2nd, at 10:00 a.m. CT (11:00 a.m. ET), and at the Jefferies Global Healthcare Conference on Wednesday, June 3rd, at 9:55 a.m. ET...
Business Wire
News Placeholder
Charles River Laboratories (CRL) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
News Placeholder
Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions
Charles River Laboratories (CRL) and MEDIPOST Co., Ltd. (KOSDAQ 078160) have entered into a strategic, non-exclusive Memorandum of Understanding (MOU) to collaborate on GMP-compliant testing, as well...
Business Wire
News Placeholder
Charles River (CRL) Reliance on International Sales: What Investors Need to Know
Evaluate Charles River's (CRL) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Zacks
News Placeholder
Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow
Charles River Laboratories International, Inc. (NYSE: CRL) today announced continued momentum in its digital pathology platform, delivering an end-to-end, AI-enabled workflow that significantly...
Business Wire
News Placeholder
Charles River Laboratories International Q1 Earnings Call Highlights
Charles River Laboratories International Q1 Earnings Call Highlights...
Yahoo! Finance: News
News Placeholder
LH vs. CRL: Which Stock Is the Better Value Option?
LH vs. CRL: Which Stock Is the Better Value Option?
Zacks
News Placeholder
These Analysts Increase Their Forecasts On Charles River After Better-Than-Expected Q1 Results
Charles River Laboratories (NYSE: CRL) beat Q1 earnings estimates but lowered its FY2026 forecast. Analysts maintain positive outlook with raised price targets.read more...
Benzinga
News Placeholder
CRL Q1 Earnings & Revenues Top Estimates, Margins Crash, Stock Down
Charles River beats Q1 earnings and revenue estimates, but margin declines and weak organic growth in key segments send shares lower in pre-market.
Zacks
<
1
2
...
>

Advertisement|Remove ads.